Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The study will evaluate the pharmacokinetics, pharmacodynamics, safety and preliminary efficacy of IDN-6556 in subjects with cirrhosis of the liver who are hospitalized for more than 24 hours due to acute deterioration of liver function.
Epistemonikos ID: 6cb2fd4d09fb951082fe18813dcd2dadd383720f
First added on: May 11, 2024